Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- Check3 days agoChange DetectedThe site revision label updates from v3.7.0 to v3.7.1, and the right-side utility toolbar is reduced.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry v3.7.0 has been added to the record history. The older revision v3.6.6 is removed from the history list.SummaryDifference0.1%

- Check45 days agoChange DetectedThe record history shows a new site revision (v3.6.6) added and the previous revision (v3.6.5) removed, indicating a recent update to the history-tracking UI.SummaryDifference0.1%

- Check67 days agoChange DetectedThe record history now lists a new version, v3.6.5, and replaces the previous v3.6.4, indicating a small update to the page’s revision history.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision label (v3.6.4) has been added to the record history, replacing the previous revision (v3.6.3). This indicates a newer build of the page.SummaryDifference0.1%

- Check103 days agoChange DetectedThe page history now shows a new site revision (v3.6.3) replacing the previous revision (v3.6.2). This indicates an updated ClinicalTrials.gov interface or backend release rather than changes to study data or content.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.